Atai Beckley N.V.(ATAI)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
ATAI Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Atai Beckley N.V. (ATAI), a Healthcare sector company. ATAI is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q3 2025), Atai Beckley N.V. reports quarterly revenue of $749.0K, net income of $-61.1M, free cash flow of $-23.7M. Top institutional holders of ATAI by reported 13-F value include Deep Track Capital,, VANGUARD CAPITAL MANAGEMENT, UBS Group AG, based on the most recent SEC filings. ATAI trades on the Nasdaq exchange and files with the SEC under CIK 1840904. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ATAI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Atai Beckley N.V. directly from SEC EDGAR.
Revenue
Q3 2025
$749.0K
Net Income
Q3 2025
$-61.1M
Free Cash Flow
Q3 2025
$-23.7M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-1.9% YoYNet Income
-271.1% YoYOperating Income
+18.2% YoYEPS (Diluted)
-272.0% YoYTotal Assets
-45.7% YoYTotal Debt
-47.4% YoYOp. Cash Flow
+2.0% YoY| Metric | FY 2024 | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Revenue | $308.0K -1.9% | $314.0K -98.5% | $20.4M | $0.00 |
| Net Income | $-149.3M -271.1% | $-40.2M +76.0% | $-167.8M +1.2% | $-169.8M |
| Operating Income | $-102.7M +18.2% | $-125.5M +7.6% | $-135.8M -30.4% | $-104.2M |
| EPS (Diluted) | $-0.93 -272.0% | $-0.25 +79.3% | $-1.21 | — |
| Total Assets | $159.4M -45.7% | $293.5M -29.1% | $414.2M +271.3% | $111.5M |
| Total Debt | $65.3M -47.4% | $124.2M | $0.00 | — |
| Operating Cash Flow | $-82.4M +2.0% | $-84.1M -33.0% | $-63.2M -204.6% | $-20.8M |
Get alerted when ATAI's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Atai Beckley N.V. including:
Top Institutional Holders of ATAI
Deep Track Capital, LP
$42.5M12,000,000 shVANGUARD CAPITAL MANAGEMENT LLC
$41.6M11,761,398 shUBS Group AG
$26.3M7,426,867 shBlackRock, Inc.
$24.2M6,835,300 shADAGE CAPITAL PARTNERS GP, L.L.C.
$20.0M5,642,758 shSUSQUEHANNA INTERNATIONAL GROUP, LLP
$18.7M5,286,326 shMILLENNIUM MANAGEMENT LLC
$15.4M4,364,096 shMORGAN STANLEY
$13.6M3,852,772 shCandriam S.C.A.
$10.9M3,086,379 shQube Research & Technologies Ltd
$10.2M2,891,942 sh
| Fund | Value | Shares |
|---|---|---|
| Deep Track Capital, LP | $42.5M | 12,000,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | $41.6M | 11,761,398 |
| UBS Group AG | $26.3M | 7,426,867 |
| BlackRock, Inc. | $24.2M | 6,835,300 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $20.0M | 5,642,758 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18.7M | 5,286,326 |
| MILLENNIUM MANAGEMENT LLC | $15.4M | 4,364,096 |
| MORGAN STANLEY | $13.6M | 3,852,772 |
| Candriam S.C.A. | $10.9M | 3,086,379 |
| Qube Research & Technologies Ltd | $10.2M | 2,891,942 |
More Healthcare Companies
View all Healthcare →Put ATAI on your watchlist
Track score changes the day Atai Beckley N.V. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ATAI a good stock to buy?
13F Pro's AI-powered analysis of Atai Beckley N.V. (ATAI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ATAI are available on the ATAI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own ATAI?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ATAI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Atai Beckley N.V.'s investment landscape.